Matthew Plunkett
2014 - CTI BioPharma
In 2014, Matthew Plunkett earned a total compensation of $2M as Executive Vice President, Chief Business Officer at CTI BioPharma, a 34% increase compared to previous year.
Compensation breakdown
| Bonus | $219,375 |
|---|---|
| Salary | $325,000 |
| Stock Awards | $1,481,271 |
| Other | $8,339 |
| Total | $2,033,985 |
Plunkett received $1.5M in stock awards, accounting for 73% of the total pay in 2014.
Plunkett also received $219.4K in bonus, $325K in salary and $8.3K in other compensation.
Rankings
In 2014, Matthew Plunkett's compensation ranked 4,449th out of 13,032 executives tracked by ExecPay. In other words, Plunkett earned more than 65.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,449 out of 13,032 | 66th |
Division Manufacturing | 1,587 out of 4,965 | 68th |
Major group Chemicals And Allied Products | 525 out of 1,690 | 69th |
Industry group Drugs | 404 out of 1,369 | 71st |
Industry Pharmaceutical Preparations | 321 out of 1,042 | 69th |
Source: SEC filing on March 28, 2017.
Plunkett's colleagues
We found three more compensation records of executives who worked with Matthew Plunkett at CTI BioPharma in 2014.